EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults

Meron Siira, Darios Getahun, Michael J Silverberg, Vin Tangpricha, Michael Goodman, Howa Yeung

The Journal of Sexual Medicine · 31.03.2023 · 20 (4) · 568-572

DOI: 10.1093/jsxmed/qdad011 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Sexual Medicine, online erschienen am 16.02.2023. Verfasst von Meron Siira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, Emory University, Atlanta, GA 30322. Hauptthemen laut MEDLINE: Transgender Persons. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many transgender persons seek hormone therapy to reduce gender dysphoria and improve quality of life, but little is known about patient satisfaction with current gender-affirming hormone therapy.

Aim

To examine patient satisfaction with current gender-affirming hormone therapy and patients’ goals of additional hormone therapy.

Methods

Transgender adults in the validated multicenter STRONG cohort (Study of Transition, Outcomes, and Gender) were asked to complete a cross-sectional survey about current and planned hormone therapy and the effects that they experienced or hoped to gain. The proportion of respondents reporting overall satisfaction with hormone therapy were compared with χ2 or Fisher exact test. Cochran-Mantel-Haenszel analysis was used to compare the covariates of interest while controlling for age at the time of survey completion. Outcomes Patient satisfaction across hormone therapies, each measured with a 5-point scale, was averaged and dichotomized.

Results

Out of 2136 eligible transgender adults, 696 (33%) completed the survey: 350 transfeminine (TF) and 346 transmasculine (TM) respondents. Most participants (80%) were satisfied or very satisfied with their current hormone therapies. TF participants and older participants were less likely to report being satisfied with their current hormone therapies than TM participants and younger participants, respectively. However, TM and TF categories were not associated with patient satisfaction after controlling for age at the time of survey completion. More TF persons planned to take additional treatment. The most frequent goals for additional hormone therapy for TF persons included breast size growth, feminine body fat distribution, and facial feature softening; for TM persons, goals included diminishing dysphoria, greater muscle mass, and masculine body fat distribution. Clinical Implications Multidisciplinary care beyond provision of hormone therapy—such as involvement of surgical, dermatologic, reproductive health, mental health, and/or gender expression care—may be important to help achieve unmet gender-affirming care goals. Strengths and Limitations This study had a modest response rate and included only respondents with private insurance, limiting generalizability.

Conclusion

Understanding patient satisfaction and goals of care will assist shared decision making and counseling in patient-centered gender-affirming therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsHumansAdultQuality of LifeCross-Sectional StudiesGoalsHormonesPersonal SatisfactionMaleFemale

Stichwörter der Autor:innen

gender-affirming hormone therapyhealth services for transgender personspatient satisfactiontransgender persons

Substanzen

Hormones

Autor:innen und Institutionen

  • Department of Dermatology, School of Medicine, Emory University, Atlanta, GA 30322.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, United States.
  • Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA 91101, United States.
  • Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, United States.
  • Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, School of Medicine, Emory University, Atlanta, GA 30322.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322.

Förderung

  • NIAMS NIH HHS
  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Siira, M., Getahun, D., Silverberg, M. J., Tangpricha, V., Goodman, M., & Yeung, H. (2023). Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults. The Journal of Sexual Medicine, 20(4), 568-572. https://doi.org/10.1093/jsxmed/qdad011

Vancouver

Siira M, Getahun D, Silverberg MJ, Tangpricha V, Goodman M, Yeung H. Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults. The Journal of Sexual Medicine. 2023;20(4):568-572. doi:10.1093/jsxmed/qdad011

BibTeX
@article{Siira2023,
  author = {Siira, Meron and Getahun, Darios and Silverberg, Michael J and Tangpricha, Vin and Goodman, Michael and Yeung, Howa},
  title = {Satisfaction with current hormone therapy and goals of additional gender-affirming care in transgender adults},
  journal = {The Journal of Sexual Medicine},
  year = {2023},
  volume = {20},
  number = {4},
  pages = {568--572},
  doi = {10.1093/jsxmed/qdad011}
}
Kostenlos starten →